David Owens is currently the President and CEO of BiologicsMD, Inc., a position he has held since 2013. He brings over 30 years of pharmaceutical and biotechnology management and commercialization experience. Mr. Owens has also been an active accredited angel investor since 2009 and has been a member of the Delaware Crossing Investor Group and the Mid-Atlantic Angel Group (MAG II) Fund. Mr. Owens was formerly the Chief Business Officer for Novira Therapeutics, Inc., a privately-held antiviral drug discovery company were he co-led a syndicated angel investment in 2011 and then a Series A financing in 2012. Prior to Novira, Mr. Owens held executive positions as Senior Vice President, and Business Unit Head of the Surgical Products Division at King Pharmaceuticals (now part of Pfizer) and as Vice President of Global Marketing & Medical Affairs at Aventis Pharma (now part of Sanofi). Earlier in his career, Mr. Owens held commercial operations roles at Genentech, Merck and Abbott Labs. Mr. Owens is a graduate of the University of Wisconsin, School of Pharmacy